PULMOTECT, INC

Address

3900 Essex Lane #250
Houston, TX, 77027-5181

Information

DUNS: 786704143
# of Employees: 0

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. Preventing and treating RSV pneumonia in immunocompromised cancer patients

    Amount: $999,372.00

    DESCRIPTION provided by applicant Pneumonia resulting from respiratory syncytial virus infections RSV is well known as a cause of morbidity and mortality in patients undergoing immune suppressiv ...

    SBIRPhase II2016Department of Health and Human Services
  2. Expanding the Market and Success Rates for Myeloablative Cancer Treatments Using PUL-042, an Innate Immune Stimulant

    Amount: $2,980,030.00

    Pulmotect Inc was founded in to translate discoveries that induce innate immune resistance in the lung into therapeutics that will provide protection from inhaled pathogens Our technology plat ...

    SBIRPhase II2015Department of Health and Human Services National Institutes of Health
  3. Boosting the innate immune system of the lungs to prevent and treat respiratory v

    Amount: $231,348.00

    7. Project Summary/Abstract Problem: Throughout the world, lower respiratory infections cause significant death and mortality. Seasonal influenza pneumonia alone causes more than 40,000 deaths a year ...

    SBIRPhase I2014Department of Health and Human Services
  4. Preventing asthma exacerbations by reducing viral respiratory infections

    Amount: $985,628.00

    DESCRIPTION (provided by applicant): An estimated 300 million people worldwide are affected by asthma, causing up to 250,000 deaths per year1,2. Asthma is a personal and public, health and economic bu ...

    SBIRPhase II2014Department of Health and Human Services
  5. Rapidly boosting innate immunity in the lungs to protect against pneumonia

    Amount: $1,305,671.00

    DESCRIPTION (provided by applicant): Pneumonia can be caused by a variety of pathogenic organisms including bacteria, fungi and viruses and is the leading cause of death worldwide. Even in developed ...

    SBIRPhase II2013Department of Health and Human Services
  6. Preventing asthma exacerbations by reducing viral respiratory infections

    Amount: $301,296.00

    DESCRIPTION (provided by applicant): Asthma is a leading cause of respiratory disease worldwide, with an estimated 300 million people affected and up to 250,000 deaths per year. Even in developed coun ...

    SBIRPhase I2012Department of Health and Human Services
  7. Rapidly boosting innate immunity in the lungs to protect against pneumonia

    Amount: $221,748.00

    DESCRIPTION (provided by applicant): Problem: Pneumonia is the leading cause of death worldwide. Even in developed countries, it continues to be the leading cause of death from infection and a serio ...

    SBIRPhase I2011Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government